Envista (NYSE:NVST) Updates FY 2025 Earnings Guidance

Key Points

• Envista has updated its FY 2025 earnings guidance, projecting an EPS of 1.050-1.15, surpassing the consensus estimate of 1.003.
• The company's stock price fell 5.4% to $18.89 during trading, with a significant trading volume of 8 million shares compared to the average of 2.6 million.
• Equities analysts have mixed ratings on Envista, with an average target price of $20.54 and a range of ratings from "sell" to "strong buy."

Envista (NYSE:NVST - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 1.050-1.15 for the period, compared to the consensus estimate of 1.003. The company issued revenue guidance of -.

Envista Stock Down 5.4%

NYSE:NVST traded down $1.08 during trading hours on Thursday, hitting $18.89. The company's stock had a trading volume of 8,021,471 shares, compared to its average volume of 2,601,591. The stock has a fifty day moving average of $19.29 and a 200-day moving average of $18.60. The stock has a market capitalization of $3.20 billion, a P/E ratio of -2.89, a price-to-earnings-growth ratio of 1.28 and a beta of 1.00. Envista has a 52-week low of $14.22 and a 52-week high of $23.00. The company has a current ratio of 2.12, a quick ratio of 1.82 and a debt-to-equity ratio of 0.43.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.24 by $0.02. Envista had a positive return on equity of 4.07% and a negative net margin of 44.90%. On average, equities analysts forecast that Envista will post 1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

NVST has been the subject of a number of research analyst reports. Piper Sandler dropped their target price on shares of Envista from $18.00 to $17.00 and set a "neutral" rating for the company in a report on Wednesday, April 30th. Baird R W raised shares of Envista from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, May 27th. Robert W. Baird raised shares of Envista from a "neutral" rating to an "outperform" rating and raised their price objective for the stock from $21.00 to $23.00 in a research note on Tuesday, May 27th. Morgan Stanley set a $16.00 price objective on shares of Envista in a research note on Tuesday, April 15th. Finally, Bank of America dropped their price objective on shares of Envista from $26.00 to $23.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Envista presently has an average rating of "Hold" and an average target price of $20.54.

Institutional Trading of Envista

Several large investors have recently bought and sold shares of the company. Royal Bank of Canada grew its position in shares of Envista by 26.6% during the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company's stock valued at $401,000 after buying an additional 4,885 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Envista by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company's stock valued at $9,821,000 after acquiring an additional 76,246 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Envista by 39.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company's stock valued at $10,859,000 after buying an additional 177,630 shares during the period. Finally, Millennium Management LLC increased its stake in shares of Envista by 218.6% during the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company's stock worth $6,627,000 after purchasing an additional 263,442 shares during the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.